Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:
*The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
1.
|
Names of Reporting Persons.
|
|
|
|
Mitchell P. Kopin
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
(a)
|
|
(b)
|
3.
|
SEC Use Only
|
|
|
4.
|
Citizenship or Place of Organization
United States of America
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power
0
|
6.
|
Shared Voting Power
195
|
7.
|
Sole Dispositive Power
0
|
8.
|
Shared Dispositive Power
195
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
195 (see Item 4)
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
0.01% (see Item 4)
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
|
IN; HC
|
1.
|
Names of Reporting Persons.
|
|
|
|
Daniel B. Asher
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
(a)
|
|
(b)
|
3.
|
SEC Use Only
|
|
|
4.
|
Citizenship or Place of Organization
United States of America
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power
0
|
6.
|
Shared Voting Power
195
|
7.
|
Sole Dispositive Power
0
|
8.
|
Shared Dispositive Power
195
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
195 (see Item 4)
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
0.01% (see Item 4)
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
|
IN; HC
|
1.
|
Names of Reporting Persons.
|
|
|
|
Intracoastal Capital LLC
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
(a)
|
|
(b)
|
3.
|
SEC Use Only
|
|
|
4.
|
Citizenship or Place of Organization
Delaware
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power
0
|
6.
|
Shared Voting Power
195
|
7.
|
Sole Dispositive Power
0
|
8.
|
Shared Dispositive Power
195
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person
195 (see Item 4)
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9)
0.01% (see Item 4)
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
|
OO
|
Item 1.
(a) Name of Issuer
Akers Biosciences, Inc. (the “Issuer”)
(b) Address of Issuer’s Principal
Executive Offices
201 Grove Road
Thorofare, New Jersey
08086
Item 2.
(a) Name of Person Filing
(b) Address of Principal Business Office or, if none,
Residence
(c) Citizenship
This Schedule 13G is being filed
on behalf of (i) Mitchell P. Kopin, an individual who is a citizen of the United States of America (“Mr. Kopin”),
(ii) Daniel B. Asher, an individual who is a citizen of the United States of America (“Mr. Asher”) and (iii)
Intracoastal Capital LLC, a Delaware limited liability company (“Intracoastal” and together with Mr. Kopin and
Mr. Asher, collectively the “Reporting Persons”).
The Reporting Persons have entered
into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 1, pursuant to which the
Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities
Exchange Act of 1934, as amended.
The principal business office
of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483.
The principal business office
of Mr. Asher is 111 W. Jackson Boulevard, Suite 2000, Chicago, Illinois 60604.
(d) Title of Class of Securities
Common Stock, no par value per share, of the Issuer
(the “Common Stock”).
(e) CUSIP Number
00973E409
Item 3. If this statement is filed pursuant
to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable.
Item
4. Ownership.
(a) and (b):
(i) Immediately
following the execution of the Securities Purchase Agreement with the Issuer on April 7, 2020 (the “SPA”) (as
disclosed in the Form 8-K filed by the Issuer with the Securities and Exchange Commission on April 8, 2019), each of the Reporting
Persons may have been deemed to have beneficial ownership of 200,000 shares of Common Stock, which consisted of (i) 150,000 shares
of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (ii) 50,000 shares
of Common Stock issued to Intracoastal upon exercise of a warrant held by Intracoastal (“Intracoastal Warrant 1”),
and all such shares of Common Stock in the aggregate represent beneficial ownership of approximately 6.4% of the Common Stock,
based on (1) 2,945,240 shares of Common Stock outstanding as of April 6, 2020 as reported by the Issuer, plus (2) 150,000 shares
of Common Stock to be issued to Intracoastal at the closing of the transaction contemplated by the SPA and (3) 50,000 shares of
Common Stock issued to Intracoastal upon exercise of Intracoastal Warrant 1. The foregoing excludes 195 shares of Common Stock
issuable upon an exercise of a second warrant held by Intracoastal (“Intracoastal Warrant 2”) because Intracoastal
Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant
1 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together
with the holder’s affiliates, and any other persons acting as a group together with the holder or any of the holder’s
affiliates, of more than 4.99% of the Common Stock. Without such blocker provision, each of the Reporting Persons may have been
deemed to have beneficial ownership of 200,195 shares of Common Stock.
(ii) As
of the close of business on April 17, 2019, each of the Reporting Persons may have been deemed to have beneficial ownership of
195 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2, and all such shares of Common Stock represent beneficial
ownership of approximately 0.01% of the Common Stock, based on (1) 2,945,240 shares of Common Stock outstanding as of April 6,
2020 as reported by the Issuer, plus (2) 766,667 shares of Common Stock in the aggregate issued at the closing of the transaction
contemplated by the SPA, (3) 50,000 shares of Common Stock issued to Intracoastal upon exercise of Intracoastal Warrant 1 and
(4) 195 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2.
(c) Number of shares
as to which each Reporting Person has:
(i) Sole power to vote or to direct the vote: 0
.
(ii) Shared power to vote or to direct the vote:
195 .
(iii) Sole power to dispose or to direct the disposition
of 0 .
(iv) Shared power to dispose or to direct the disposition
of 195 .
Item
5. Ownership of Five Percent or Less of a Class
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than 5 percent of the class of securities, check the following ☑.
Item
6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item
7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
Not applicable.
Item
8. Identification and Classification of Members of the Group
Not applicable.
Item
9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below I
certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely
in connection with a nomination under §240.14a-11.
SIGNATURE
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: April 17, 2020
|
/s/ Mitchell P. Kopin
|
|
Mitchell P. Kopin
|
|
|
|
/s/ Daniel B. Asher
|
|
Daniel B. Asher
|
|
|
|
Intracoastal Capital LLC
|
|
|
|
|
By:
|
/s/ Mitchell P. Kopin
|
|
|
Mitchell P. Kopin, Manager
|
Exhibit 1
JOINT FILING AGREEMENT
The undersigned acknowledge
and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent
amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing
additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments,
and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible
for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason
to believe that such information is inaccurate.
Date: April 17, 2020
|
/s/
Mitchell P. Kopin
|
|
Mitchell
P. Kopin
|
|
|
|
/s/
Daniel B. Asher
|
|
Daniel
B. Asher
|
|
|
|
Intracoastal
Capital LLC
|
|
|
|
|
By:
|
/s/
Mitchell P. Kopin
|
|
|
Mitchell
P. Kopin, Manager
|
Page 8 of 8